Success Stories: In Just 4 Months, Our Team Obtains NIW Approval for a Research Fellow in Immunology Hailing from the Philippines

Posted by wegreened on October 28, 2022 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“Thank you for all your hard work to get this accomplished!”

On March 1^st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Research Fellow

Country of Origin: Philippines

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 1^st, 2022

Processing Time: 4 months

Case Summary:

Whenever our team at NAILG gets an NIW (National Interest Waiver) case, we make sure to look for the following:

Client’s updated CVs
Transcripts from Universities and colleges
Certificates of merit
Records of excellence in the field of research
Publication, citation, and review record
Funding information
Letters of recommendation

These are the steps our team replicated while preparing the case of a research fellow in immunology from the Philippines. She wanted to continue her work in utilizing advanced cell culture and biostatistics techniques to examine the mechanisms of lung inflammation, injury, and repair in order to develop novel treatment modalities and therapeutics for chronic lung diseases. Along with the details of her research endeavor, we also collected the following evidence:

Her research has resulted in 5 peer-reviewed scientific articles (3 of them first-authored).
These publications have been cited a total of 48 times according to Google Scholar.
Her major funding source was the National Institutes of Health.
She had been able to bring forth 4 letters of support from other experts in the field. Two short excerpts are quoted below from these to prove her value to the country:

“[Client’s] objective through her work is to continue examining the mechanisms of lung inflammation in order to develop effective therapies for treating lung diseases such as COPD and asthma. Her focus is in direct alignment with the institute's goal, demonstrating that [client’s] work is of importance to the health and economic interests of the United States.”

“...a significant number of Americans suffer from various symptoms such as shortness of breath, chest tightness, coughing, and wheezing. There is no cure for these respiratory illnesses and the damage is irreversible, which stresses the acute importance of [client’s] ongoing research via in vivo experimentations and biostatistical methods to enhance healthcare treatments nationwide.”

Thus, when the USCIS approved her NIW case just 4 months from filing, we were glad to know that her work on utilizing advanced cell culture and biostatistics techniques to examine the mechanisms of lung inflammation, injury, and repair in order to develop novel treatment modalities and therapeutics for chronic lung diseases could continue on American soil for our benefit. Our team congratulates her on this victory and we thank our team for their tireless efforts.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%